Sign in
4

Changes in Ownership

Guardant Health, Inc. Filed Acc 0001576280-25-000205

Director sold 26 shares at $49.47 ($1,286)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

POTTER MYRTLE S · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-18 Sale : show line 1 in the form 10b5-1 −26 $49.47 $1,286 18,154 D
Open-market sales · 26 sh · avg $49.47 · $1,286

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-06-18 Grant or award : show line 2 in the form 10b5-1 Stock Option (Right to Buy) +6,833 $50.57 2035-06-18 6,833 6,833 D
2025-06-18 Grant or award : show line 3 in the form 10b5-1 Restricted Stock Units +4,203 $0.00 4,203 4,203 D
Loading xslF345X05/wk-form4_1750455650.xml…